DS
SGYP

DRW Securities’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

DRW Securities’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-160,000
Closed -$739K – 141
2015
Q1 		$739K Buy
+160,000
New +$520K 0.12% 48

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

DRW Securities's SGYP Position: Q2 2015 in Review

DRW Securities sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2015, closing a stake of 160,000 shares — an estimated $739K sold.

DRW Securities first reported a position in SGYP in Q1 2015 and held it in 1 quarter. The position peaked at $739K in Q1 2015. 123 funds tracked by Wall St. Rank hold SGYP as of Q2 2015.

  • DRW Securities reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2015 after selling out during the quarter.
  • DRW Securities sold 160,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2015, an estimated $739K.
  • DRW Securities first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2015 and held it in 1 quarter.
  • DRW Securities's Synergy Pharmaceuticals, Inc Common Stock position peaked at $739K in Q1 2015.
  • 123 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2015.

Based on DRW Securities's 13F filing for Q2 2015, filed 14 Aug 2015.